SI1493435T1 - Controlled Release Compositions of Betahistine - Google Patents

Controlled Release Compositions of Betahistine

Info

Publication number
SI1493435T1
SI1493435T1 SI200331296T SI200331296T SI1493435T1 SI 1493435 T1 SI1493435 T1 SI 1493435T1 SI 200331296 T SI200331296 T SI 200331296T SI 200331296 T SI200331296 T SI 200331296T SI 1493435 T1 SI1493435 T1 SI 1493435T1
Authority
SI
Slovenia
Prior art keywords
betahistine
controlled release
release compositions
optionally
coating layer
Prior art date
Application number
SI200331296T
Other languages
Slovenian (sl)
Inventor
Flavio Fossati
Anna Perachiotti
Marco Carnaghi
Luciano Marcelloni
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Publication of SI1493435T1 publication Critical patent/SI1493435T1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

The invention relates to controlled-release formulation of betahistine, or of its pharmaceutically acceptable salts, comprising:a) a core comprising a granulate of betahistine, an organic or inorganic acid and an hydrophilic polymer or mixtures of hydrophilic polymers;b) optionally, a first coating layer comprising an hydrophilic polymer and a water insoluble excipient;c) optionally, a second coating layer comprising hydrophilic polymers and colouring agents.
SI200331296T 2003-07-04 2003-07-04 Controlled Release Compositions of Betahistine SI1493435T1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03015172A EP1493435B1 (en) 2003-07-04 2003-07-04 Controlled Release Compositions of Betahistine

Publications (1)

Publication Number Publication Date
SI1493435T1 true SI1493435T1 (en) 2008-10-31

Family

ID=33427119

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200331296T SI1493435T1 (en) 2003-07-04 2003-07-04 Controlled Release Compositions of Betahistine

Country Status (17)

Country Link
EP (1) EP1493435B1 (en)
CN (1) CN1816323A (en)
AT (1) ATE395048T1 (en)
CY (1) CY1108551T1 (en)
DE (1) DE60320965D1 (en)
DK (1) DK1493435T3 (en)
EA (1) EA011569B1 (en)
EC (1) ECSP066267A (en)
ES (1) ES2306827T3 (en)
GE (1) GEP20084349B (en)
LT (1) LT5379B (en)
MX (1) MXPA06000090A (en)
PL (1) PL379374A1 (en)
PT (1) PT1493435E (en)
SI (1) SI1493435T1 (en)
TN (1) TNSN05326A1 (en)
WO (1) WO2005004850A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8802139B2 (en) 2003-06-26 2014-08-12 Intellipharmaceutics Corp. Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
BRPI0912126A2 (en) 2008-05-27 2015-11-03 Univ Melbourne method of treating mammals with eustachian tube dysfunction
DE102012105528A1 (en) * 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Pharmaceutical form for the release of active substances
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
PT3431078T (en) 2017-07-20 2021-04-21 Intas Pharmaceuticals Ltd Non-pulsatile prolonged-release betahistine oral solid compositions
CN111249237A (en) * 2019-12-21 2020-06-09 乐普恒久远药业有限公司 Betahistine hydrochloride medicine and preparation method thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2397840B1 (en) 1977-07-22 1981-03-20 Cherqui Jean
FR2432313A1 (en) * 1978-08-01 1980-02-29 Foulhoux Pierre Micro:granules contg. beta-histine - for controlled release and less side effects useful in treating Menieres syndrome
IT1229237B (en) 1989-05-08 1991-07-26 Prodotti Formenti SALTS OF (2- (PYRIDYL) ETHYL) METHYLAMINE
GB9104854D0 (en) * 1991-03-07 1991-04-17 Reckitt & Colmann Prod Ltd Sustained release compositions
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
IT1309591B1 (en) 1999-03-05 2002-01-24 Formenti Farmaceutici Spa COMPOSITIONS WITH BETAISTINE CONTROLLED RELEASE.

Also Published As

Publication number Publication date
PL379374A1 (en) 2006-09-04
DE60320965D1 (en) 2008-06-26
CN1816323A (en) 2006-08-09
EA011569B1 (en) 2009-04-28
EP1493435A1 (en) 2005-01-05
ECSP066267A (en) 2006-07-28
DK1493435T3 (en) 2008-09-08
CY1108551T1 (en) 2014-04-09
LT2006009A (en) 2006-06-27
WO2005004850A1 (en) 2005-01-20
EP1493435B1 (en) 2008-05-14
LT5379B (en) 2006-10-25
ATE395048T1 (en) 2008-05-15
EA200501908A1 (en) 2006-08-25
TNSN05326A1 (en) 2007-07-10
ES2306827T3 (en) 2008-11-16
PT1493435E (en) 2008-08-14
GEP20084349B (en) 2008-04-10
MXPA06000090A (en) 2006-04-07

Similar Documents

Publication Publication Date Title
LT2006009A (en) Controlled release compositions of betahistine
WO2007000778A3 (en) Modified release pharmaceutical compositions on the basis of two polymers and processes thereof
BR0002880A (en) Solid thermoformable controlled-release pharmaceutical composition
EA200900930A1 (en) COMPOSITION OF TABLETS WITH PROLONGED CLEARING, CONTAINING PRAMIPEXOL OR ITS PHARMACEUTICAL SATURABLE SALT, METHOD OF ITS MANUFACTURE AND ITS USE
WO2006106514A3 (en) Electrospun dosage form and method of producing the same
BRPI0509194A (en) formulation and method of coated tablet
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
NO20000284D0 (en) Tannic acid polymer compositions for controlled release of pharmaceutical agents, especially in the oral cavity
DE60211464D1 (en) PHARMACEUTICAL FORMULATIONS WITH CONTROLLED ACTIVE INGREDIENT CONTAINING MILKY ACID POLYMER, AND THEIR PREPARATION
ATE258044T1 (en) METHOD FOR PRODUCING A BANDED DOSE FORM FOR PROLONGED RELEASE OF AN ACTIVE INGREDIENT
PT885014E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING POLYMERS ORTO ESTER TAMPONADOS
ATE442852T1 (en) DELAYED-RELEASE MEDICINAL COMPRISING TRIMETAZIDINE AND METHOD FOR THE PRODUCTION
NO20032737D0 (en) Solid thermoformable pharmaceutical composition for the controlled release of ivabradine
NO326689B1 (en) Pyrrolidine derivatives, their use, pharmaceutical composition and process for the preparation of the compounds
HRP20090190T1 (en) Pharmaceutical composition comprising a salt of mirtazapine
ITTO20000613A0 (en) ANTI-REFLECTIVE ORGANIC POLYMERS FOR COATINGS AND THEIR PREPARATION PROCEDURE.
GB2374078B (en) Organic anti-reflective coating polymers, anti-reflective coating composition comprising the same and preparation methods thereof
WO2003096874A3 (en) Coated sustained release tablets of a hygroscopic compound for once-a-day therapy
GB2424185A (en) Cough mixture comprising codeine linctus and guaifenesin
WO2008122994A3 (en) Stable pharmaceutical compositions of clopidogrel bisulfate and process of preparation thereof
ATE305799T1 (en) STABILIZED PHARMACEUTICAL COMPOSITIONS AND METHOD FOR THE PRODUCTION THEREOF, COMPRISING AN ANTIBIOTIC AND AN EXPECTORANT
GB2364316B (en) Organic anti-reflective coating polymer, anti-reflective coating composition and methods of preparation thereof
BR0115206A (en) Hydrolytically unstable compositions
DE60221787D1 (en) Fast release compositions containing cefuroxime axetil
WO2009047800A3 (en) Oral controlled release composition of carvedilol